Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Ironwood Pharmaceuticals Inc

+ Add to Watchlist

IRWD:US

15.5800 USD 0.4600 2.87%

As of 20:10:00 ET on 01/30/2015.

Snapshot for Ironwood Pharmaceuticals Inc (IRWD)

Open: 15.9400 Day's Range: 15.5700 - 16.3900 Volume: 868,071
Previous Close: 16.0400 52wk Range: 9.0100 - 17.1100 1-Yr Rtn: +12.33%

Stock Chart for IRWD

No chart data available.
  • IRWD:US 15.5800
  • 1D
  • 1M
  • 1Y
16.0400
Interactive IRWD Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IRWD

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.5500
Est. EPS (USD) (12/2014) -1.3020
Est. PEG Ratio -
Market Cap (M USD) 2,175.47
Shares Outstanding (M) 123.69
30 Day Average Volume 854,705
Price/Book (mrq) 20.1046
Price/Sale (ttm) 47.9193
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IRWD

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for IRWD

Ironwood Pharmaceuticals, Inc. is a pharmaceutical company. The Company discovers, develops, manufactures, and commercializes marketed drugs. Ironwood products used in treatments of cholesterol, gastrointestinal and cardiovascular diseases, pain, inflammation, and others.

Peter M HechtCEO/Co-FounderHalley E GilbertSenior VP/Chief Legal Ofcr
Mark G CurrieSenior VP/Pres:Research & DevThomas GraneySenior VP:Finance/CFO
More Company Profile & Key Executives for IRWD

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil